Trial intelligence / Profile preview

Ketamine versus remifentanil for intraoperative stress and blood glucose during cholecystectomy

IRCT201701237745N5Phase 3Completed

Sponsor
Yasouj University of Medical Sciences
Start
Jan 2015
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketamine and remifentanil in cholelithiasis (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Intraoperative stress and Intraoperative blood glucose level. Started Jan 2015; status: completed.

02

Drugs

ketamineremifentanil
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on IRCT201701237745N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201701237745N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call